Anne Ekdahl is a geriatrician at the Vrinnevihospital in Sweden and the president of the Swedish Association of Geriatric Medicine.
As in many other countries in Europe it is not always easy to be a geriatrician. I came back from the EUGMS 2013 Congress in Venice full of power, spirit and pride in being a geriatrician: and then it was suddenly back to reality. Continue reading →
Tomas Welsh is a Clinical Lecturer in the Medicine of Older People at the University of Nottingham, England. (First blogged on the BGS blog)
Antihypertensive therapy is effective even in the oldest old. However, the large trials of antihypertensive medications, even in older people, frequently excluded people with dementia. This causes difficulties in applying these findings to many of our typical patient group.
People with dementia are more likely to be physically frail, are at higher risk of adverse events due to polypharmacy and are more likely to experience orthostatic hypotension than their cognitively intact peers. There is reason to suspect, therefore, that the risk-benefit ratio of treating hypertension may be different in this group and many clinicians intuitively feel this to be the case. Continue reading →
The inaugural UK conference on sarcopenia was held in central London on 9th July 2013.
Delegates included clinicians, therapists, nutritionists and scientists, with representatives from Spain, Belgium, the Netherlands, Poland, the Ukraine, the United States and Japan. The meeting was organised and chaired by Professor Avan Aihie Sayer, MRC Clinical Scientist and Professor of Geriatric Medicine at the MRC Lifecourse Epidemiology Unit in Southampton, who opened the meeting with an overview of why sarcopenia is important. Sarcopenia is the loss of skeletal muscle mass and function with age. It is common in older men and women and has serious health consequences and significant healthcare costs. Continue reading →